Skip to main content
. 2021 Dec 17;12:750675. doi: 10.3389/fgene.2021.750675

TABLE 5.

Mechanisms of immunotherapy resistance in glioblastoma.

Category of resistance Example of resistance References
Primary CNS immune privilege: 1. BBB 2. CNS lymphatics 3. Resident microglia (Carson et al., 2006)
Intrinsic tumor heterogeneity: 1. Classical subtypes 2. Non-classical hybrid cellular states (Patel et al., 2014)
Immunosuppressive tumor microenvironment: 1. T cell dysfunction & exhaustion 2. Monocyte/macrophage populations (Woroniecka et al., 2018) (Marvel and Gabrilovich, 2015)
Secondary SOC-induced changes: 1. Lymphopenia secondary to TMZ 2. Immunosuppressive cell populations upregulated secondary to dexamethasone (Gustafson et al., 2010) (Karachi et al., 2018)
Immunotherapeutic pressure: 1. Expression of alternative checkpoints (TIM3) 2. Epigenetic changes secondary to chronic IFN-γ 3. Loss of tumor antigen expression (Koyama et al., 2016) (Benci et al., 2016)